Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)
ophthalmic optics ophthalmic ophthalmic viscoelastics viscosurgical devices introduction core changes ophthalmic injection fluidity clinical application case national food safety standard food additives caproic phenol crystallization point accelerated life-test
YY 0861-2024 in English

YY 0861-2024 in English

TO BE VALID

Ophthalmic optics—Ophthalmic viscosurgical devices

  • Issued on:2024-07-08
  • Implemented on:2027-07-20
  • File Format:PDF
  • Delivery:Via email within 2~4 business days
Price(USD): $449.00
$436.00
Standard No: YY 0861-2024
Document status: TO BE VALID
Title in English: Ophthalmic optics—Ophthalmic viscosurgical devices
Title in Chinese: 眼科光学 眼用粘弹剂
Language: English
File Format: Electronic (PDF)
Delivery: Via email within 2~4 business days
Issued on: 2024-07-08
Implemented on: 2027-07-20
ICS Classification: 11.040.70-Ophthalmic equipment
Chinese Classification: C40-Medical optical instrument and endoscope
Professional Classification: YY-Pharmaceutics
Related Keywords: ophthalmic optics ophthalmic
ophthalmic viscoelastics
viscosurgical devices introduction core changes
ophthalmic
injection fluidity clinical application case


Introduction

Core changes in the standard revision

Technical parameters YY 0861-2011 YY 0861-2024 Significance of changes
Particle control No quantitative indicator 10μm≤3000 particles/mL
25μm≤300 particles/mL
Clear surgical safety threshold
Visible foreign matter Not required New test items Prevention of postoperative complications
Sterilization requirements Conventional sterilization Increase EO residue control Improve biocompatibility

Analysis of key technical requirements

Rheological properties

The standard requires the measurement of the absolute complex viscosity (η*) of ophthalmic viscoelastics in the frequency range of 0.01-100Hz, where:

  • Zero shear viscosity reflects static protection ability
  • Elastic modulus (G') determines spatial maintenance
  • Viscous modulus (G'') affects injection fluidity

Clinical application case: During cataract surgery, high-elastic viscoelastics are more suitable for maintaining anterior chamber space, while low-shear viscosity products are more conducive to injection through a narrow-bore cannula.


Analysis of differences in international standards

Compared with ISO 15798:2022, my country's standard mainly strengthens:

  1. Add the detection method of the "Chinese Pharmacopoeia" (osmotic pressure, visible foreign matter, etc.)
  2. Refine the quantitative indicators such as particle limit
  3. Delete the clinical evaluation chapter (in line with domestic regulatory requirements)

Implementation Recommendations

Manufacturers

  • Establish a database correlating rheological properties and clinical performance
  • Strengthen the compatibility verification of primary packaging (such as silicone oil migration risk)
  • Use real-time aging test to verify product stability

Medical institutions

  • Preoperative inspection of viscoelastic agent packaging integrity
  • Pay attention to the cleaning method instructions in the product manual
  • Record changes in rheological properties during surgery (such as viscosity decrease after phacoemulsification)

Technology evolution trend

Next-generation products will focus on:

  • Intelligent responsive viscoelastic agents (pH/temperature sensitive)
  • Integration of anti-inflammatory drug sustained-release function
  • Application of biodegradable materials

Sample only — not a preview of YY 0861-2024
Page: 1 / 0
100%

Loading PDF document...

Error loading PDF. Please make sure the file is valid and try again.

We also recommend